首页> 美国卫生研究院文献>other >Efficacy and Safety of a Traditional Chinese Herbal Formula Xuefu Zhuyu Decoction for Hypertension
【2h】

Efficacy and Safety of a Traditional Chinese Herbal Formula Xuefu Zhuyu Decoction for Hypertension

机译:中药血府逐瘀汤对高血压的疗效和安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The cardioprotective role of xuefu zhuyu decoction (XZD), a well-known classical herbal formula, has been documented for hypertension treatment recently. This study aims to summarize the efficacy and safety of XZD in treating hypertension.Seven databases were searched to identify randomized controlled trials evaluating the efficacy of XZD in hypertensive patients. Fifteen studies involving 1364 hypertensive patients were included. All studies compared XZD and antihypertensive drugs with antihypertensive drugs used alone.In all, 15 studies reported significant effects of XZD for lowering blood pressure compared with the control group (P < 0.05), and 7 studies reported significant effects of XZD for improving symptoms compared with the control group (P < 0.00001). Meanwhile, studies reported XZD was more efficacious than antihypertensive drugs in improving total cholesterol, triglycerides, low-density lipoprotein cholesterol, homocysteine, hemorheology, carotid intima-media thickness, and left ventricular mass index (P < 0.05). No severe adverse event was reported.This meta-analysis provides evidence that XZD is beneficial for hypertension. Although concerns regarding selective bias and methodologic flaws were raised, our findings suggests XZD as a new candidate cardioprotective drug for hypertension, which should be given priority for future preclinical and clinical studies.
机译:最近有文献记载,著名的经典草药配方血府逐瘀汤(XZD)对心脏有保护作用。本研究旨在总结XZD治疗高血压的有效性和安全性。检索了七个数据库,以鉴定评估XZD在高血压患者中的疗效的随机对照试验。纳入了15项研究,涉及1364名高血压患者。所有研究都将XZD和降压药与单独使用降压药进行了比较。总共有15项研究报告了XZD与对照组相比有明显的降压效果(P <0.05),有7项研究表明XZD具有改善症状的显着效果。对照组(P <0.00001)。同时,研究表明XZD在改善总胆固醇,甘油三酸酯,低密度脂蛋白胆固醇,高半胱氨酸,血液流变学,颈动脉内膜中层厚度和左心室质量指数方面比降压药更有效(P <0.05)。没有严重不良事件的报道。这项荟萃分析提供了XZD对高血压有益的证据。尽管引起了人们对选择性偏倚和方法学缺陷的担忧,但我们的研究结果表明,XZD是高血压的一种新型候选心脏保护药物,应在未来的临床前和临床研究中优先考虑使用XZD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号